Southeast Asia Digital Pharmaceutical Supply Chain Management Market (2025 to 2035)

Southeast Asia Digital Pharmaceutical Supply Chain Management Market Summary:

The Southeast Asia digital pharmaceutical supply chain management market size was valued at USD 320 Million in 2025 and is projected to reach USD 850 Million by 2035, expanding at a CAGR of 10.40% from 2026 to 2035. Market growth is supported by increasing pharmaceutical digitization initiatives, growing adoption of cloud-based supply chain platforms, rising demand for real-time inventory visibility, and government efforts to improve drug traceability and regulatory compliance across Southeast Asian countries.

Southeast Asia Digital Pharmaceutical Supply Chain Management Market Revenue Forecast, 2022–2035 (US$ Million)

Key Market Takeaways & Insights

• Southeast Asia digital pharmaceutical supply chain management market accounted for a significant share of the Asia-Pacific healthcare supply chain software industry in 2025.

• The market is expected to witness strong growth owing to increasing pharmaceutical manufacturing activities and cross-border trade integration.

• By Component, the Software segment held the largest market share in 2025.

• By Deployment Mode, the Cloud-Based segment held the largest market share in 2025.

• By End User, the Pharmaceutical Manufacturers segment held the largest market share in 2025

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Southeast Asia Digital Pharmaceutical Supply Chain Management Market Size: USD 320 Million
• 2035 Southeast Asia Digital Pharmaceutical Supply Chain Management Market Size: USD 850 Million
• CAGR (2026-2035): 10.40%

Disease Epidemiology Analysis:

• Pharmaceutical demand and medicine consumption trends

• Drug distribution and accessibility analysis

• Prescription volume assessment

• Regional pharmaceutical demand distribution

Treatment Landscape Overview:

• Pharmaceutical distribution network analysis

• Current supply chain management pathways

• Drug accessibility and availability challenges

• Comparative digital supply chain platform positioning

Southeast Asia Digital Pharmaceutical Supply Chain Management Market Outlook Analysis Conservative, Likely, Optimistic, (US$ Million), 2025–2035

Market Drivers:

Rising Adoption of Pharmaceutical Serialization and Track-and-Trace Systems

The increasing implementation of pharmaceutical serialization and track-and-trace systems across Southeast Asia is significantly driving demand for digital pharmaceutical supply chain management solutions. Governments and regulatory authorities are strengthening drug traceability requirements to combat counterfeit medicines, improve patient safety, and enhance supply chain transparency. Digital platforms enable real-time monitoring of product movement, inventory management, and regulatory compliance throughout the pharmaceutical value chain. Growing pharmaceutical exports and cross-border trade activities are further accelerating the adoption of integrated supply chain technologies across manufacturers, distributors, and healthcare providers.

Growth of Pharmaceutical Manufacturing and Regional Distribution Networks

The expansion of pharmaceutical manufacturing hubs and regional distribution networks across Southeast Asia is further supporting market growth. Countries such as Singapore, Thailand, Malaysia, Indonesia, and Vietnam are investing heavily in pharmaceutical production capabilities and logistics infrastructure. Digital supply chain management platforms help organizations optimize procurement, warehousing, transportation, inventory visibility, and demand forecasting. The growing complexity of pharmaceutical supply chains and increasing emphasis on operational efficiency continue to drive investment in advanced digital solutions throughout the region.

Market Restraint:

High Implementation and Integration Costs

The digital pharmaceutical supply chain management industry faces challenges related to high implementation and integration costs. Deploying enterprise-level supply chain management systems requires substantial investments in software platforms, cloud infrastructure, cybersecurity frameworks, workforce training, and process transformation. Small and medium-sized pharmaceutical companies often face financial constraints when adopting comprehensive digital solutions. Integration with legacy systems and diverse stakeholder networks can further increase deployment complexity and operational expenses.

Data Security and Regulatory Compliance Challenges

Furthermore, pharmaceutical supply chains manage large volumes of sensitive operational, commercial, and regulatory information. Organizations must comply with various national regulations regarding data privacy, pharmaceutical traceability, and cybersecurity. Differences in digital regulations across Southeast Asian countries create compliance challenges for multinational pharmaceutical companies operating across multiple markets. Concerns regarding cyber threats, data breaches, and system interoperability may slow digital transformation initiatives among some market participants.

Market Opportunities:

Growing Adoption of Artificial Intelligence, Predictive Analytics, and Cloud-Based Supply Chain Platforms

The increasing adoption of artificial intelligence (AI), predictive analytics, and cloud-based supply chain management platforms is creating substantial growth opportunities for the Southeast Asia digital pharmaceutical supply chain management market. Pharmaceutical companies are increasingly utilizing AI-enabled solutions to improve demand forecasting, inventory optimization, route planning, procurement efficiency, and risk management. Cloud-based platforms provide real-time visibility across supply chain operations while enabling seamless collaboration among manufacturers, distributors, logistics providers, pharmacies, and healthcare institutions. These capabilities support faster decision-making and improve overall supply chain resilience.

The growing integration of Internet of Things (IoT), blockchain technology, and digital traceability systems is further creating significant market opportunities. IoT-enabled sensors help monitor pharmaceutical product conditions throughout transportation and storage, ensuring quality and regulatory compliance. Blockchain-based solutions enhance transparency, security, and product authentication while reducing the risk of counterfeit medicines. In addition, government-led healthcare digitalization initiatives, increasing pharmaceutical exports, expansion of e-pharmacy networks, and rising investments in healthcare logistics infrastructure are expected to accelerate the adoption of digital pharmaceutical supply chain management solutions throughout Southeast Asia during the forecast period.

Southeast Asia Digital Pharmaceutical Supply Chain Management Market Segmentations Analysis:

By Component

the market is divided into Software, Services, and Analytics Solutions. Software accounted for the largest share of 52.0% in 2025, supported by increasing adoption of digital platforms for inventory management, procurement, warehouse operations, order processing, and pharmaceutical supply-chain visibility. Services represented 28.0%, covering implementation, integration, consulting, training, and maintenance activities, while Analytics Solutions accounted for 20.0%, driven by demand for demand forecasting, inventory optimization, predictive analytics, and data-driven decision-making. Digital systems increasingly support real-time visibility and automation across supply-chain processes.

By Deployment Mode

the market is segmented into Cloud-Based and On-Premises solutions. Cloud-Based solutions dominated with a 63.0% share in 2025, reflecting the advantages of scalable infrastructure, remote accessibility, easier integration, centralized data management, and lower upfront IT requirements. On-Premises solutions accounted for 37.0%, particularly among larger pharmaceutical organizations and institutions that require greater control over data, infrastructure, security, and integration with existing enterprise systems.

By End User

the market is categorized into Pharmaceutical Manufacturers, Pharmaceutical Distributors, and Hospitals & Healthcare Providers. Pharmaceutical Manufacturers held the largest share of 42.0% in 2025, as manufacturers increasingly require digital systems for production planning, procurement, inventory control, batch management, order fulfilment, and product traceability. Pharmaceutical Distributors accounted for 32.0%, supported by the need for warehouse, transportation, order, and inventory visibility. Hospitals & Healthcare Providers represented 26.0%, driven by the need to manage medicine inventories, replenishment, dispensing, expiry monitoring, and supply availability. WHO also emphasizes inventory, expiry-date monitoring, ordering, and distribution as important supply-chain management functions.

By Application

the market is segmented into Inventory & Warehouse Management, Procurement & Order Management, Demand Forecasting & Planning, Transportation & Distribution Management, Pharmaceutical Traceability & Serialization, and Supplier & Vendor Management. Inventory & Warehouse Management was the leading application with a 25.0% share in 2025, reflecting the importance of real-time inventory visibility, stock-level monitoring, expiry management, and warehouse optimization. Procurement & Order Management accounted for 20.0%, followed by Demand Forecasting & Planning at 18.0%, Transportation & Distribution Management at 15.0%, Pharmaceutical Traceability & Serialization at 12.0%, and Supplier & Vendor Management at 10.0%. Traceability is becoming particularly important because digital traceability systems can provide near-real-time monitoring of pharmaceutical products throughout the supply chain and improve supply-chain efficiency and product integrity.

Southeast Asia Digital Pharmaceutical Supply Chain Management Market Regional Share Analysis and Forecast, 2025–2035 & 2026-35

Singapore Digital Pharmaceutical Supply Chain Management Market Analysis

Singapore accounted for approximately 22.00% of the Southeast Asia digital pharmaceutical supply chain management market in 2025 and was valued at nearly USD 70.4 Million. The market benefits from advanced digital infrastructure, strong pharmaceutical manufacturing capabilities, and government support for healthcare digitalization initiatives.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Singapore Market Size: USD 70.4 Million
• 2035 Singapore Market Size: USD 144.5 Million
• CAGR (2026-2033): 7.50%

Drivers

• Strong pharmaceutical manufacturing ecosystem

• Advanced digital infrastructure

• Government support for digital transformation

• Increasing adoption of cloud-based supply chain platforms

Restraints

• High implementation costs

• Data privacy and cybersecurity concerns

• Integration challenges with legacy systems

• Limited scalability for smaller organizations

Opportunities

• Expansion of AI-enabled supply chain solutions

• Growth in pharmaceutical exports and regional logistics hubs

Malaysia Digital Pharmaceutical Supply Chain Management Market Analysis

Malaysia represented approximately 14.00% of the Southeast Asia market in 2025 and was valued at around USD 44.8 Million. The market is supported by growing pharmaceutical production activities, healthcare modernization programs, and increasing investments in digital supply chain technologies.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Malaysia Market Size: USD 44.8 Million
• 2035 Malaysia Market Size: USD 110.5 Million
• CAGR (2026-2033): 9.40%

Drivers

• Expanding pharmaceutical manufacturing sector

• Growing healthcare expenditure

• Rising adoption of digital logistics solutions

• Government healthcare modernization initiatives

Restraints

• Infrastructure gaps in certain regions

• Limited digital integration among SMEs

• Regulatory compliance challenges

• High deployment costs

Opportunities

• Increasing investment in cloud-based SCM platforms

• Expansion of pharmaceutical distribution networks

Thailand Digital Pharmaceutical Supply Chain Management Market Analysis

Thailand accounted for approximately 15.00% of the Southeast Asia market in 2025 and was valued at nearly USD 48 Million. The market is experiencing growth due to pharmaceutical manufacturing expansion, healthcare digitalization initiatives, and increasing focus on supply chain optimization.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Thailand Market Size: USD 48 Million
• 2035 Thailand Market Size: USD 127.5 Million
• CAGR (2026-2033): 10.40%

Drivers

• Strong pharmaceutical production base

• Rising demand for supply chain visibility

• Government digital healthcare initiatives

• Increasing healthcare investments

Restraints

• Integration complexity

• High technology implementation costs

• Workforce training requirements

• Cybersecurity concerns

Opportunities

• Adoption of blockchain-based traceability systems

• Expansion of digital pharmaceutical logistics networks

Indonesia Digital Pharmaceutical Supply Chain Management Market Analysis

Indonesia represented approximately 21.00% of the Southeast Asia market in 2025 and was valued at around USD 67.2 Million. The market is expanding rapidly due to increasing pharmaceutical production, healthcare infrastructure modernization, and rising adoption of digital supply chain technologies. Growing demand for efficient inventory management and pharmaceutical traceability solutions continues to support market growth.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Indonesia Market Size: USD 67.2 Million
• 2035 Indonesia Market Size: USD 204 Million
• CAGR (2026-2033): 11.70%

Drivers

• Expanding pharmaceutical manufacturing activities

• Increasing healthcare digitization initiatives

• Rising demand for supply chain visibility

• Growth in pharmaceutical distribution networks

Restraints

• Infrastructure disparities across remote regions

• High technology deployment costs

• Limited interoperability among systems

• Cybersecurity and data protection concerns

Opportunities

• Expansion of cloud-based supply chain platforms

• Growing adoption of AI-driven forecasting solutions

Vietnam Digital Pharmaceutical Supply Chain Management Market Analysis

Vietnam accounted for approximately 11.00% of the Southeast Asia market in 2025 and was valued at nearly USD 35.2 Million. The market is witnessing significant growth owing to increasing pharmaceutical manufacturing investments, expansion of healthcare services, and growing implementation of digital technologies across supply chain operations.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Vietnam Market Size: USD 35.2 Million
• 2035 Vietnam Market Size: USD 110.5 Million
• CAGR (2026-2033): 11.90%

Drivers

• Growing pharmaceutical production capabilities

• Increasing healthcare expenditure

• Rising adoption of digital logistics solutions

• Government support for digital transformation

Restraints

• Limited digital infrastructure in rural areas

• Regulatory implementation challenges

• Integration costs for legacy systems

• Skilled workforce shortages

Opportunities

• Expansion of pharmaceutical export activities

• Increasing investment in supply chain automation

Philippines Digital Pharmaceutical Supply Chain Management Market Analysis

Philippines represented approximately 10.00% of the Southeast Asia market in 2025 and was valued at around USD 32 Million. The market is supported by healthcare modernization initiatives, increasing pharmaceutical demand, and rising adoption of digital supply chain management platforms across healthcare organizations.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Philippines Market Size: USD 32 Million
• 2035 Philippines Market Size: USD 93.5 Million
• CAGR (2026-2033): 11.50%

Drivers

• Growing pharmaceutical distribution activities

• Increasing healthcare awareness

• Rising demand for inventory optimization

• Government healthcare modernization programs

Restraints

• Limited infrastructure in certain regions

• Budget constraints among smaller organizations

• Data security concerns

• Technology integration challenges

Opportunities

• Expansion of digital pharmaceutical logistics

• Growing adoption of cloud-based SCM solutions

Cambodia Digital Pharmaceutical Supply Chain Management Market Analysis

Cambodia represented approximately 1.40% of the Southeast Asia digital pharmaceutical supply chain management market in 2025 and was valued at around USD 4.5 Million. The market is gradually expanding due to improving healthcare infrastructure, increasing pharmaceutical imports, and growing government focus on healthcare digitization. Rising demand for efficient pharmaceutical distribution and inventory management solutions is supporting market growth.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Cambodia Market Size: USD 4.5 Million
• 2035 Cambodia Market Size: USD 11.9 Million
• CAGR (2026-2033): 10.90%

Drivers

• Growing healthcare infrastructure development

• Increasing pharmaceutical import volumes

• Rising healthcare digitization initiatives

• Expansion of pharmacy and hospital networks

Restraints

• Limited digital infrastructure

• Budget constraints among healthcare facilities

• Shortage of skilled IT professionals

• Dependence on imported technologies

Opportunities

• Expansion of cloud-based supply chain solutions

• Increasing adoption of pharmaceutical traceability systems

Myanmar Digital Pharmaceutical Supply Chain Management Market Analysis

Myanmar accounted for approximately 1.10% of the Southeast Asia market in 2025 and was valued at nearly USD 3.4 Million. The market is witnessing gradual growth driven by increasing pharmaceutical demand, healthcare modernization efforts, and growing awareness regarding supply chain efficiency and medicine accessibility.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Myanmar Market Size: USD 3.4 Million
• 2035 Myanmar Market Size: USD 8.9 Million
• CAGR (2026-2033): 10.00%

Drivers

• Rising pharmaceutical consumption

• Growing healthcare investments

• Increasing need for inventory optimization

• Expansion of healthcare service providers

Restraints

• Rising pharmaceutical consumption

• Growing healthcare investments

• Increasing need for inventory optimization

• Expansion of healthcare service providers

Opportunities

• Development of digital logistics platforms

• Adoption of pharmaceutical inventory management systems

Laos Digital Pharmaceutical Supply Chain Management Market Analysis

Laos represented approximately 0.70% of the Southeast Asia market in 2025 and was valued at around USD 2.2 Million. The market is supported by healthcare system improvements, growing pharmaceutical trade activities, and increasing interest in digital technologies for supply chain management.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Laos Market Size: USD 2.2 Million
• 2035 Laos Market Size: USD 6 Million
• CAGR (2026-2033): 10.30%

Drivers

• Improving healthcare infrastructure

• Increasing pharmaceutical distribution activities

• Growing healthcare expenditure

• Rising government healthcare initiatives

Restraints

• Limited technological infrastructure

• High implementation costs

• Lack of skilled workforce

• Limited awareness of advanced SCM solutions

Opportunities

• Expansion of cloud-enabled platforms

• Growing investment in healthcare logistics

Brunei Digital Pharmaceutical Supply Chain Management Market Analysis

Brunei accounted for approximately 0.40% of the Southeast Asia market in 2025 and was valued at nearly USD 1.1 Million. The market benefits from strong healthcare spending, advanced healthcare infrastructure, and increasing adoption of digital technologies across pharmaceutical operations.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Brunei Market Size: USD 1.1 Million
• 2035 Brunei Market Size: USD 3 Million
• CAGR (2026-2033): 10.30%

Drivers

• Advanced healthcare infrastructure

• Strong government healthcare support

• High adoption of digital technologies

• Growing focus on supply chain optimization

Restraints

• Small market size

• Dependence on imported pharmaceutical products

• Limited local technology ecosystem

• Integration challenges

Opportunities

• Expansion of AI-enabled supply chain platforms

• Growth in pharmaceutical inventory automation

Rest of Southeast Asia Digital Pharmaceutical Supply Chain Management Market Analysis

The Rest of Southeast Asia digital pharmaceutical supply chain management market is expanding steadily due to increasing healthcare investments, pharmaceutical trade growth, and ongoing digital transformation initiatives. Countries across the region are focusing on improving supply chain visibility, medicine availability, and regulatory compliance through digital technologies.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Rest of Southeast Asia Market Size: USD 11.2 Million
• 2035 Rest of Southeast Asia Market Size: USD 29.7 Million
• CAGR (2026-2033): 10.30%

Drivers

• Growing pharmaceutical demand

• Increasing healthcare modernization programs

• Rising investment in logistics infrastructure

• Expansion of digital healthcare initiatives

Restraints

• Uneven technology adoption

• Limited financial resources

• Infrastructure challenges

• Regulatory fragmentation

Opportunities

• Expansion of pharmaceutical traceability systems

• Growth in regional healthcare supply chain integration

Southeast Asia Digital Pharmaceutical Supply Chain Management Market Key Players

• SAP SE
• Oracle Corporation
• IBM Corporation
• Blue Yonder
• Infor Inc.
• Manhattan Associates, Inc.
• Microsoft Corporation
• Amazon Web Services (AWS)
• Google Cloud
• TraceLink Inc.
• LogiPharma
• Tecsys Inc.
• Descartes Systems Group
• Project44 Inc.
• E2open LLC
• Coupa Software Inc.
• MPO Supply Chain
• ToolsGroup
• QAD Inc.
• Others

Southeast Asia Digital Pharmaceutical Supply Chain Management Market Recent Developments

• In January 2025, SAP SE expanded its digital supply chain capabilities by introducing advanced AI-powered planning and pharmaceutical inventory optimization solutions. The enhancement supports improved forecasting accuracy, warehouse efficiency, and end-to-end supply chain visibility for pharmaceutical manufacturers and distributors operating across Southeast Asia.
• In March 2025, Oracle Corporation enhanced its cloud-based supply chain management platform with real-time pharmaceutical logistics monitoring and procurement automation capabilities. The platform aims to improve operational efficiency, compliance management, and inventory transparency across healthcare supply chains.
• In June 2025, QIAGEN partnered with Foresight Diagnostics to develop companion diagnostic kits for lymphoma, leveraging enzyme-based molecular assays for biomarker detection. This collaboration supports the development of targeted diagnostics aligned with precision medicine, enabling more accurate patient stratification. It also increases demand for advanced enzyme-based assays in oncology diagnostics, thereby contributing to growth in the IVD enzyme market.
• In September 2024, IBM Corporation strengthened its blockchain-enabled pharmaceutical traceability solutions to support product authentication, regulatory compliance, and counterfeit drug prevention across pharmaceutical distribution networks in Asia-Pacific.
• In February 2025, Blue Yonder introduced enhanced predictive analytics and demand forecasting capabilities designed to optimize pharmaceutical logistics, inventory planning, and transportation management processes.
• In June 2024, TraceLink Inc. expanded its pharmaceutical digital network solutions to strengthen drug serialization, supply chain visibility, and regulatory compliance management across global and regional pharmaceutical ecosystems.
• In October 2024, Kinaxis Inc. enhanced its supply chain orchestration platform with advanced scenario planning and risk management capabilities for pharmaceutical manufacturers seeking greater supply chain resilience and operational agility.
• In August 2024, Infor Inc. launched upgraded cloud-based healthcare supply chain management functionalities supporting inventory optimization, warehouse automation, and procurement efficiency across pharmaceutical organizations.
• In November 2024, Manhattan Associates, Inc. expanded warehouse management and logistics optimization solutions designed to improve pharmaceutical inventory accuracy, fulfillment efficiency, and cold-chain visibility.

Southeast Asia Digital Pharmaceutical Supply Chain Management Market Regulatory Landscape Analysis

FDA / HSA / NPRA / BPOM / Thai FDA Approvals

Southeast Asian countries are increasingly implementing pharmaceutical traceability and digital supply chain regulations to improve medicine safety, reduce counterfeit drug circulation, and strengthen supply chain transparency. Regulatory agencies such as the Health Sciences Authority, National Pharmaceutical Regulatory Agency, and Food and Drug Administration Thailand require pharmaceutical companies to maintain accurate product tracking, inventory records, and distribution documentation throughout the supply chain.

• Pharmaceutical supply chain compliance requirements
• Drug serialization and traceability regulations
• Digital inventory monitoring standards
• Product authentication and reporting requirements.

Southeast Asia Digital Pharmaceutical Supply Chain Management Market Patent & IP Landscape

Patent expiry analysis

Patent protection and proprietary technology ownership play a critical role in the digital pharmaceutical supply chain management market. Companies actively develop and patent technologies related to supply chain visibility, artificial intelligence-based demand forecasting, inventory optimization, blockchain-enabled traceability, warehouse automation, and pharmaceutical logistics management. The expiration of patents may increase market competition by allowing broader adoption of previously protected technologies and encouraging innovation among software providers.

IP competitiveness

The market is characterized by strong intellectual property competition among enterprise software providers, cloud platform vendors, supply chain technology companies, and pharmaceutical traceability solution developers. Organizations continue to invest in patent portfolios focused on artificial intelligence, machine learning, predictive analytics, blockchain integration, cloud computing, and digital logistics optimization technologies to strengthen their competitive positioning.

Licensing agreements

Licensing agreements are becoming increasingly important as technology providers collaborate with pharmaceutical manufacturers, distributors, healthcare institutions, and logistics companies to accelerate digital transformation initiatives. These agreements facilitate access to advanced software platforms, analytics tools, cloud infrastructure, and pharmaceutical traceability solutions while reducing implementation timelines.

Innovation clusters

Innovation activities are concentrated within major technology and healthcare hubs across Southeast Asia, including Singapore, Malaysia, and Thailand. These innovation clusters support collaboration among pharmaceutical companies, software vendors, logistics providers, healthcare organizations, research institutions, and government agencies. Increasing investments in digital health infrastructure and supply chain modernization continue to drive innovation in pharmaceutical logistics technologies.

Southeast Asia Digital Pharmaceutical Supply Chain Management Market Segmentations

By Product

• Software
• Hardware
• Services

By Deployment Mode

• Cloud-Based
• On-Premises
• Hybrid

By Technology

• AI & ML
• IoT
• Cloud Computing
• RFID & Barcode
• Blockchain
• Advanced Analytics
• Other Technologies

By Application

• Inventory Management
• Warehouse Management
• Procurement & Sourcing
• Demand Forecasting & Planning
• Logistics & Distribution Management
• Pharmaceutical Serialization & Track-and-Trace
• Supplier & Vendor Management
• Order Management
• Cold Chain Management
• Supply Chain Visibility & Monitoring

By End User

• Pharmaceutical Manufacturers
• Pharmaceutical Distributors & Wholesalers
• Hospitals & Healthcare Providers
• Pharmacies & Retailers
• 3PL Providers
• CMOs & CDMOs
• Government & Public Healthcare Organizations

Region & Country

South-East Asia

• Singapore
• Malaysia
• Thailand
• Indonesia
• Vietnam
• Philippines
• Cambodia
• Myanmar
• Laos
• Brune
• Rest of Southeast Asia